CNS market to surpass $80 bn in 2025, driven by MS and psychiatric drug innovation: GlobalData EP News Bureau Mar 26, 2025 The revival of CNS drug development is being fueled by advancements in neuroimmunology and neurodegeneration, moving beyond…
